VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema. (Q39741051)

From Wikidata
Jump to navigation Jump to search
scientific article
edit
Language Label Description Also known as
English
VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema.
scientific article

    Statements

    VEGF-C gene therapy augments postnatal lymphangiogenesis and ameliorates secondary lymphedema (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit